Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-21-000935
Filing Date
2021-02-16
Accepted
2021-02-16 14:37:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP aptoa1_21621.htm SC 13G/A 53563
  Complete submission text file 0001085146-21-000935.txt   55458
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Subject) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49893 | Film No.: 21636430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

EIN.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A